Twinbeech Capital LP Makes New Investment in Keurig Dr Pepper Inc. (NASDAQ:KDP)

Twinbeech Capital LP acquired a new position in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 268,532 shares of the company's stock, valued at approximately $8,625,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in Keurig Dr Pepper by 23.6% in the fourth quarter. Vanguard Group Inc. now owns 119,587,162 shares of the company's stock worth $3,841,140,000 after purchasing an additional 22,856,757 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Keurig Dr Pepper by 10.3% during the fourth quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company's stock valued at $1,946,561,000 after acquiring an additional 5,646,179 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Keurig Dr Pepper by 36.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company's stock valued at $1,755,564,000 after acquiring an additional 14,473,054 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Keurig Dr Pepper by 8.7% during the fourth quarter. Geode Capital Management LLC now owns 24,511,039 shares of the company's stock valued at $784,974,000 after acquiring an additional 1,962,195 shares during the period. Finally, Invesco Ltd. boosted its holdings in shares of Keurig Dr Pepper by 19.6% during the fourth quarter. Invesco Ltd. now owns 21,605,610 shares of the company's stock valued at $693,972,000 after acquiring an additional 3,539,463 shares during the period. Institutional investors and hedge funds own 93.99% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on KDP shares. Argus initiated coverage on shares of Keurig Dr Pepper in a report on Wednesday, April 16th. They set a "buy" rating and a $40.00 price target for the company. UBS Group lifted their price objective on shares of Keurig Dr Pepper from $40.00 to $42.00 and gave the company a "buy" rating in a research note on Thursday, April 17th. Piper Sandler upgraded shares of Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $35.00 to $40.00 in a research note on Wednesday, April 9th. JPMorgan Chase & Co. lifted their price objective on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Finally, Wells Fargo & Company restated an "overweight" rating on shares of Keurig Dr Pepper in a research note on Tuesday, February 25th. Four analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Keurig Dr Pepper presently has a consensus rating of "Moderate Buy" and an average price target of $39.33.

Insider Buying and Selling at Keurig Dr Pepper

In other news, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $35.59, for a total value of $427,080.00. Following the transaction, the insider now owns 154,511 shares in the company, valued at $5,499,046.49. This represents a 7.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Robert James Gamgort sold 416,000 shares of the company's stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $34.29, for a total value of $14,264,640.00. Following the completion of the transaction, the chairman now owns 3,237,066 shares in the company, valued at $110,998,993.14. This represents a 11.39% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 84,863,850 shares of company stock valued at $2,772,203,450 in the last 90 days. 0.40% of the stock is currently owned by corporate insiders.

Keurig Dr Pepper Price Performance

NASDAQ KDP opened at $33.83 on Tuesday. The stock's 50-day moving average price is $34.24 and its two-hundred day moving average price is $33.02. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50. The company has a market cap of $45.95 billion, a PE ratio of 20.50, a PEG ratio of 2.42 and a beta of 0.52. Keurig Dr Pepper Inc. has a 1 year low of $30.12 and a 1 year high of $38.28.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.04. The firm had revenue of $3.64 billion for the quarter, compared to the consensus estimate of $3.57 billion. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The business's revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.38 EPS. On average, analysts predict that Keurig Dr Pepper Inc. will post 1.92 EPS for the current year.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

Want to see what other hedge funds are holding KDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.